治疗药监测市场:目前分析与预测(2022-20230年)

预计 2022 年至 2030 年治疗药物监测市场的复合年增长率将达到 10% 左右。治疗药物监测 (TDM) 测量患者血液和其他体液中的药物浓度，以最大限度地提高药物治疗的功效和安全性。TDM 的目的是确保患者根据个人特征（如年龄、体重、遗传和其他医疗问题）接受正确的药物剂量。TDM常用于治疗窗较窄的药物，即药物的最低有效浓度与其危险浓度之间差距较小的药物。通过监测药物浓度，医疗保健专业人员可以改变实现治疗效果所需的剂量和频率，从而最大限度地降低副作用的风险。全球癌症、糖尿病和心脏病等慢性疾病的患病率不断上升，推动了对治疗药物监测的需求不断增长。例如，根据疾病预防控制中心的数据，大约有1800万20岁以上的美国人患有心脏病，每年有近65万人死于心脏病。这些统计数据表明，治疗药物监测有助于减少和优化需要长期药物治疗的慢性病患者的药物治疗，例如癌症、糖尿病和心血管疾病，并将有助于未来的市场增长。为发展做出贡献 此外，由于医疗保健专业人员的意识不断增强，治疗药物监测市场预计将增长。然而，设备成本高、监管严格等市场製约因素正在阻碍全球市场的增长。

治疗药物监测在北美越来越受欢迎。癌症等慢性病患病率的不断上升正在推动该地区治疗药物监测市场的需求。对个性化医疗不断增长的需求是 TDM 的一个亮点，因为它使医疗保健提供者能够根据患者特定的药代动力学和药效学特征为个体患者量身定製药物治疗。技术进步也促进了治疗药物监测市场的增长。例如，2020年6月，Quest Diagnostics推出了针对免疫抑製剂霉酚酸的新治疗药物监测测试。政府不断加大推广 TDM 的力度，进一步推动了该地区市场的增长。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对治疗药监测市场带来的影响

第6章 全球治疗药监测市场收益，2020-2030年

第7章 市场洞察:各产品类型

• 消耗品
• 设备

第8章 市场洞察:各技术

• 免疫测量
• 蛋白质体学技术
• 其他

第9章 市场洞察:各药物类别

• 抗癫痫药
• 抗生素
• 免疫抑制剂
• 向精神性
• 抗心律不整药

第10章 市场洞察:各终端用户

• 医院实验室
• 民间实验室
• 其他

第11章 市场洞察:各地区

• 北美的治疗药监测市场
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲的治疗药监测市场
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲地区
• 亚太地区治疗药监测市场
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他地区的治疗药监测市场

第12章 治疗药监测市场动态

• 推动市场要素
• 市场课题
• 影响分析

第13章 治疗药监测市场机会

第14章 治疗药监测市场趋势&洞察

第15章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第16章 价值链分析

第17章 价格分析

第18章 策略性洞察能力

第19章 竞争模式

• 竞争情形
  • 波特的五力分析

第20章 企业简介

• Roche AG
• Siemens Healthcare GmbH
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• bioMerieux, Inc.
• Bayer AG
• Alere, Inc

第21章 免责声明

The therapeutic drug monitoring market is expected to register a CAGR of approx. 10% over the period of 2022-2030. Therapeutic drug monitoring (TDM) measures drug concentrations in a patient's blood or other bodily fluids to maximize the efficacy and security of pharmacological therapy. TDM's purpose is to guarantee that a patient receives the correct medicine dose depending on individual characteristics such as age, weight, genetics, and other medical problems. TDM is commonly employed for medications with a narrow therapeutic range, which means there is a tiny gap between the drug's minimum effective concentration and hazardous concentration. Healthcare practitioners can alter the amount or frequency of delivery as needed to achieve the intended therapeutic benefit while minimizing the risk of unwanted effects by monitoring medication levels. The growing demand for therapeutic drug monitoring can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, cardiovascular disease, etc. across the globe. For instance, according to the CDC, around 18 million Americans aged 20 and above have heart disease and nearly 650,000 Americans die of heart disease each year. Owing to the glaring statistics therapeutic drug monitoring help to reduce or optimize drug therapy in the patient suffering from chronic diseases such as cancer, diabetes, and cardiovascular disease, etc. which require long-term drug therapy which would contribute to the growth of the market in the forthcoming period as well. Furthermore, the therapeutic drug monitoring market is anticipated to grow on account of the increasing awareness among healthcare professionals. However, some of the restraints in the market, including the high cost of the equipment and stringent regulations are impeding the growth of this market all over the world.

Based on product type, the market is segmented into consumables and devices. Among them, the consumables segment captured a significant share of the market in 2021. This is due to the increasing prevalence of chronic diseases which is boosting this segment. Moreover, the increasing demand for new technology-based, cost-effective kits and the use of reagents in the R&D area is also boosting the growth of the segment of the market.

Based on the technology, the market is bifurcated into immunoassays, proteomic technologies, and others. Among them, the immunoassays segment is expected to grow at a higher CAGR in the market. This is due to the availability of highly specific and reliable immunoassay which is likely to aid the growth of the segment. Moreover, the rising adoption rate of advanced techniques and the requirement of minimal training to handle the equipment also boosted the growth of the segment.

Based on the drug class, the therapeutic drug monitoring market has been classified as anti-epileptics, antibiotics, immunosuppressants, psychoactive, and anti-arrhythmic drugs. Among them, the anti-epileptics category grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The increasing prevalence of epilepsy and seizures are the factors that help in boosting the segment. Moreover, the rising growth in the number of Anti-epileptic drugs is also likely to aid the segment growth.

Based on the end-user, the therapeutic drug monitoring market has been classified as hospital labs, private labs, and others. Among them, the hospital labs segment is expected to grow at a higher CAGR in the market. This is due to the availability of accurate patient information, such as age, metabolism, ethnicity, and drug performance history in the hospitals which boost the segment growth. Moreover, the increasing use of computerized entry of patient history and information records is more likely to boost the growth of the market segment.

For a better understanding of the market adoption of therapeutic drug monitoring, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. Therapeutic drug monitoring has gained increasing popularity in North America due to various factors. The increasing prevalence of chronic diseases such as cancer, etc. is boosting the demand for the therapeutic drug monitoring market in this region. The growing demand for personalized medicine is becoming the highlight for TDM as it allows healthcare providers to tailor drug therapy to individual patients based on their unique pharmacokinetic and pharmacodynamics profiles. The advancement in technology is also attributed to the growth of the therapeutic drug monitoring market. For instance, In June 2020, Quest Diagnostics launched a new therapeutic drug monitoring test for the immunosuppressive drug, Mycophenolic Acid. Increasing government initiatives to promote TDM further boosted the growth of the market in the region.

Some of the major players operating: Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., Bayer AG, Alere, Inc among others. Several M&A's along with partnerships have been undertaken.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Therapeutic Drug Monitoring Market
• 2.2. Research Methodology of the Therapeutic Drug Monitoring Market
• 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE THERAPEUTIC DRUG MONITORING MARKET

6 GLOBAL THERAPEUTIC DRUG MONITORING MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Consumables
• 7.2. Devices

8 MARKET INSIGHTS BY TECHNOLOGY

• 8.1. Immunoassays
• 8.2. Proteomic Technologies
• 8.3. Others

9 MARKET INSIGHTS BY DRUG CLASS

• 9.1. Anti-Epileptics
• 9.2. Antibiotics
• 9.3. Immunosuppressants
• 9.4. Psychoactive
• 9.5. Anti-Arrhythmic Drugs

10 MARKET INSIGHTS BY END-USER

• 10.1. Hospital Labs
• 10.2. Private Labs
• 10.3. Others

11 MARKET INSIGHTS BY REGION

• 11.1 NORTH AMERICA THERAPEUTIC DRUG MONITORING MARKET
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Rest of North America
• 11.2 EUROPE THERAPEUTIC DRUG MONITORING MARKET
  • 11.2.1 Germany
  • 11.2.2 France
  • 11.2.3 United Kingdom
  • 11.2.4 Spain
  • 11.2.5 Italy
  • 11.2.6 Rest of Europe
• 11.3 ASIA PACIFIC THERAPEUTIC DRUG MONITORING MARKET
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 Rest of Asia Pacific
• 11.4 REST OF THE WORLD THERAPEUTIC DRUG MONITORING MARKET

12 THERAPEUTIC DRUG MONITORING MARKET DYNAMICS

• 12.1 Market Drivers
• 12.2 Market Challenges
• 12.3 Impact Analysis

13 THERAPEUTIC DRUG MONITORING MARKET OPPORTUNITIES

14 THERAPEUTIC DRUG MONITORING MARKET TRENDS & INSIGHTS

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1 Demand Side Analysis
• 15.2 Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

• 19.1. Competitive Landscape
  • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

• 20.1. Roche AG
• 20.2. Siemens Healthcare GmbH
• 20.3. Thermo Fisher Scientific, Inc.
• 20.4. Bio-Rad Laboratories, Inc.
• 20.5. Beckman Coulter, Inc.
• 20.6. Abbott Laboratories, Inc.
• 20.7. Agilent Technologies, Inc.
• 20.8. bioMerieux, Inc.
• 20.9. Bayer AG
• 20.10. Alere, Inc

21 DISCLAIMER